Cargando…

Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels

The activity of cytochrome P450 enzymes depends on the enzyme NADPH P450 oxidoreductase (POR). The aim of this study was to investigate the activity of the equine CYP3A94 using a system that allows to regulate the POR protein levels in mammalian cells. CYP3A94 and the equine POR were heterologously...

Descripción completa

Detalles Bibliográficos
Autores principales: Dettwiler, Ramona, Schmitz, Andrea L., Plattet, Philippe, Zielinski, Jana, Mevissen, Meike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240602/
https://www.ncbi.nlm.nih.gov/pubmed/25415624
http://dx.doi.org/10.1371/journal.pone.0113540
_version_ 1782345741581156352
author Dettwiler, Ramona
Schmitz, Andrea L.
Plattet, Philippe
Zielinski, Jana
Mevissen, Meike
author_facet Dettwiler, Ramona
Schmitz, Andrea L.
Plattet, Philippe
Zielinski, Jana
Mevissen, Meike
author_sort Dettwiler, Ramona
collection PubMed
description The activity of cytochrome P450 enzymes depends on the enzyme NADPH P450 oxidoreductase (POR). The aim of this study was to investigate the activity of the equine CYP3A94 using a system that allows to regulate the POR protein levels in mammalian cells. CYP3A94 and the equine POR were heterologously expressed in V79 cells. In the system used, the POR protein regulation is based on a destabilizing domain (DD) that transfers its instability to a fused protein. The resulting fusion protein is therefore degraded by the ubiquitin-proteasome system (UPS). Addition of “Shield-1” prevents the DD fusion protein from degradation. The change of POR levels at different Shield-1 concentrations was demonstrated by cytochrome c reduction, Western immunoblot analysis, and immunocytochemistry. The alteration of CYP3A94 activity was investigated using a substrate (BFC) known to detect CYP3A4 activity. Equine CYP3A94 was demonstrated to be metabolically active and its activity could be significantly elevated by co-expression of POR. Cytochrome c reduction was significantly increased in V79-CYP3A94/DD-POR cells compared to V79-CYP3A94 cells. Surprisingly, incubation with different Shield-1 concentrations resulted in a decrease in POR protein shown by Western immunoblot analysis. Cytochrome c reduction did not change significantly, but the CYP3A94 activity decreased more than 4-fold after incubation with 500 nM and 1 µM Shield-1 for 24 hours. No differences were obtained when V79-CYP3A94 POR cells with and without Shield-1 were compared. The basal activity levels of V79-CYP3A94/DD-POR cells were unexpectedly high, indicating that DD/POR is not degraded without Shield-1. Shield-1 decreased POR protein levels and CYP3A94 activity suggesting that Shield-1 might impair POR activity by an unknown mechanism. Although regulation of POR with the pPTuner system could not be obtained, the cell line V79-CYP3A94/DD-POR system can be used for further experiments to characterize the equine CYP3A94 since the CYP activity was significantly enhanced with co-expressed POR.
format Online
Article
Text
id pubmed-4240602
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42406022014-11-26 Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels Dettwiler, Ramona Schmitz, Andrea L. Plattet, Philippe Zielinski, Jana Mevissen, Meike PLoS One Research Article The activity of cytochrome P450 enzymes depends on the enzyme NADPH P450 oxidoreductase (POR). The aim of this study was to investigate the activity of the equine CYP3A94 using a system that allows to regulate the POR protein levels in mammalian cells. CYP3A94 and the equine POR were heterologously expressed in V79 cells. In the system used, the POR protein regulation is based on a destabilizing domain (DD) that transfers its instability to a fused protein. The resulting fusion protein is therefore degraded by the ubiquitin-proteasome system (UPS). Addition of “Shield-1” prevents the DD fusion protein from degradation. The change of POR levels at different Shield-1 concentrations was demonstrated by cytochrome c reduction, Western immunoblot analysis, and immunocytochemistry. The alteration of CYP3A94 activity was investigated using a substrate (BFC) known to detect CYP3A4 activity. Equine CYP3A94 was demonstrated to be metabolically active and its activity could be significantly elevated by co-expression of POR. Cytochrome c reduction was significantly increased in V79-CYP3A94/DD-POR cells compared to V79-CYP3A94 cells. Surprisingly, incubation with different Shield-1 concentrations resulted in a decrease in POR protein shown by Western immunoblot analysis. Cytochrome c reduction did not change significantly, but the CYP3A94 activity decreased more than 4-fold after incubation with 500 nM and 1 µM Shield-1 for 24 hours. No differences were obtained when V79-CYP3A94 POR cells with and without Shield-1 were compared. The basal activity levels of V79-CYP3A94/DD-POR cells were unexpectedly high, indicating that DD/POR is not degraded without Shield-1. Shield-1 decreased POR protein levels and CYP3A94 activity suggesting that Shield-1 might impair POR activity by an unknown mechanism. Although regulation of POR with the pPTuner system could not be obtained, the cell line V79-CYP3A94/DD-POR system can be used for further experiments to characterize the equine CYP3A94 since the CYP activity was significantly enhanced with co-expressed POR. Public Library of Science 2014-11-21 /pmc/articles/PMC4240602/ /pubmed/25415624 http://dx.doi.org/10.1371/journal.pone.0113540 Text en © 2014 Dettwiler et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dettwiler, Ramona
Schmitz, Andrea L.
Plattet, Philippe
Zielinski, Jana
Mevissen, Meike
Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title_full Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title_fullStr Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title_full_unstemmed Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title_short Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels
title_sort heterologous expression of equine cyp3a94 and investigation of a tunable system to regulate co-expressed nadph p450 oxidoreductase levels
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240602/
https://www.ncbi.nlm.nih.gov/pubmed/25415624
http://dx.doi.org/10.1371/journal.pone.0113540
work_keys_str_mv AT dettwilerramona heterologousexpressionofequinecyp3a94andinvestigationofatunablesystemtoregulatecoexpressednadphp450oxidoreductaselevels
AT schmitzandreal heterologousexpressionofequinecyp3a94andinvestigationofatunablesystemtoregulatecoexpressednadphp450oxidoreductaselevels
AT plattetphilippe heterologousexpressionofequinecyp3a94andinvestigationofatunablesystemtoregulatecoexpressednadphp450oxidoreductaselevels
AT zielinskijana heterologousexpressionofequinecyp3a94andinvestigationofatunablesystemtoregulatecoexpressednadphp450oxidoreductaselevels
AT mevissenmeike heterologousexpressionofequinecyp3a94andinvestigationofatunablesystemtoregulatecoexpressednadphp450oxidoreductaselevels